Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Nowak

Showing results (371-380 of 441) with videos related to

Pageof 45
Sort By:
Oncoimmunology|July 4, 2015
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogenJenette Creaney, Shaokang Ma, Sophie A Sneddon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimatesBelinda E Kiely, Andrew J Martin, Martin H N Tattersall, et al.
Plos One|September 12, 2009
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growthRobbert G van der Most, Andrew J Currie, Amanda L Cleaver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II StudyDean A Fennell, Paul Baas, Paul Taylor, et al.
Neuro-Oncology Practice|September 16, 2024
A nurse-led intervention for carers of people with high-grade glioma: A case series of carers reporting high distressGeorgia K B Halkett, Emma McDougall, Melissa Berg, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and ResearchersGeorgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Scientific Data|May 3, 2024
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyWee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, et al.
American Journal of Human Genetics|May 3, 2001
Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin geneB Ilkovski, S T Cooper, K Nowak, et al.
Nuclear Medicine and Biology|May 24, 2023
Automated radiosynthesis of [<sup>89</sup>Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivoChristian W Wichmann, Stan Poniger, Nancy Guo, et al.
Eukaryotic Cell|January 25, 2011
Functional study of genes essential for autogamy and nuclear reorganization in ParameciumJacek K Nowak, Robert Gromadka, Marek Juszczuk, et al.
Pageof 45

Showing results (371-380 of 441) with videos related to

Sort By:
Pageof 45
Oncoimmunology|July 4, 2015
Strong spontaneous tumor neoantigen responses induced by a natural human carcinogenJenette Creaney, Shaokang Ma, Sophie A Sneddon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
The median informs the message: accuracy of individualized scenarios for survival time based on oncologists' estimatesBelinda E Kiely, Andrew J Martin, Martin H N Tattersall, et al.
Plos One|September 12, 2009
Cyclophosphamide chemotherapy sensitizes tumor cells to TRAIL-dependent CD8 T cell-mediated immune attack resulting in suppression of tumor growthRobbert G van der Most, Andrew J Currie, Amanda L Cleaver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II StudyDean A Fennell, Paul Baas, Paul Taylor, et al.
Neuro-Oncology Practice|September 16, 2024
A nurse-led intervention for carers of people with high-grade glioma: A case series of carers reporting high distressGeorgia K B Halkett, Emma McDougall, Melissa Berg, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and ResearchersGeorgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Scientific Data|May 3, 2024
Time-course RNAseq data of murine AB1 mesothelioma and Renca renal cancer following immune checkpoint therapyWee Loong Chin, Rachael M Zemek, Caitlin M Tilsed, et al.
American Journal of Human Genetics|May 3, 2001
Nemaline myopathy caused by mutations in the muscle alpha-skeletal-actin geneB Ilkovski, S T Cooper, K Nowak, et al.
Nuclear Medicine and Biology|May 24, 2023
Automated radiosynthesis of [<sup>89</sup>Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivoChristian W Wichmann, Stan Poniger, Nancy Guo, et al.
Eukaryotic Cell|January 25, 2011
Functional study of genes essential for autogamy and nuclear reorganization in ParameciumJacek K Nowak, Robert Gromadka, Marek Juszczuk, et al.
Pageof 45